06 Diabetes mellitus retinopathy

(1)

PART 6: DIABETIC RETINOPATHY

Books, Book Chapters, Guidelines, Reports, Proceedings

1. Ahmad Fadzil MH, Nor Fariza Ngah, et al. Analysis of foveal avascular zone in colour fundus images for grading of diabetic retinopathy severity. Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) 2010. p.5632-5

2. Ahmad Zikri R, Hadzli H, Syed Farid SA, Chen AH, Miswanudin M. A proposed diabetic retinopathy classification algorithm with statistical inference of exudates

detectionInternational Conference on Electrical, Electronics and System Engineering (ICEESE) 2013. p.90-5.

3.

Izzuna Mudla MG, Noormah MD, Mohd Said M. Health technology assessment report: Bevacizumab for age-related macular degeneration and diabetic reinopathy. Kuala Lumpur: Ministry of Health, Malaysia, 2009

http://www.moh.gov.my/attachments/5603.pdf

4. Lim ST, Zaki WMDW, Hussain A, Lim SL, Kusalavan S. Automatic classification of diabetic macular edema in digital fundus images. IEEE Colloquium on Humanities, Science and Engineering (CHUSER) 2011. p.265-9.

Dissertations, Theses

1. Amelah MAQ. A study on the association of serum lipid profle with retinal hard exudates among patients with type 2 diabetes mellitus in Hosptial USM. MSc Dissertation, Universiti Sains Malaysia, 2008.

2. Ng, ZX. .Studies on the receptor for advanced glycation end-product (RAGE) gene polymorphisms, pro-inflammatory biomarkers and oxidative-glycation indices in Malaysian patients with diabetic retinopathy. PhD Thesis, University of Malaya, 2012 3. Zainudin MA. Risk Factors for Diabetic Retinopathy among the Diabetic Patients

attending the Eye Clinic in University Malaya Medical Centre, Kuala Lumpur. MPH Dissertation, University of Malaya, 2000

Reviews, Editorials, Commentaries

1.

Hassan SS, Bong DB, Premsenthil M. Detection of neovascularization in diabetic retinopathy. J Digit Imaging 2012;25(3):437-44

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3348992

2.

Lock JH, Fong KC. Retinal laser photocoagulation. Med J Malaysia 2010;65(1):88,94; quiz 95

http://www.e-mjm.org/2010/v65n1/Retinal_Laser_Photocoagulation.pdf

3.

Mallika PS, Tan AK, Aziz S, et al. Diabetic retinopathy and the effect of pregnancy. Malaysian Family Physician 2010;5(1):2-5

http://www.e-mfp.org/issues/2010v5n1/pdf/Diabetic_retinopathy.pdf

4. Muhaya M. The eye in diabetes. Hosp Med 2003;64(11):673-6

5.

Ong HT. Aspirin in diabetes: beware of retinopathy. Arch Intern Med

2000;160(19):3004

http://archinte.jamanetwork.com/article.aspx?articleid=526243

Original research

1. Abougalambou SSI, Abougalambou ASI. Risk factors associated with diabetic retinopathy among type 2 diabetes patients at teaching hospital in Malaysia. Diabetes Metab Syndr 2014.

2.

Addoor KR, Bhandary SV, Khanna R, et al. Assessment of awareness of diabetic retinopathy among the diabetics attending the peripheral diabetic clinics in Melaka, Malaysia. Med J Malaysia 2011;66(1):48-52

(2)

3.

Adzura S, Muhaya M, Normalina M, et al. Correlation of serum insulin like growth factor-I with retinopathy in Malaysian pregnant diabetics. Int J Ophthalmol 2011;4(1):69-72

4. Ahmad Fadzil MH, Izhar LI, Nugroho HA, et al. Analysis of retinal fundus images for grading of diabetic retinopathy severity. Med Biol Eng Comput 2011;49(6):693-700 5. Ahmad Fadzil MH, Izhar LI, Nugroho HA. Determination of foveal avascular zone in

diabetic retinopathy digital fundus images. Comput Biol Med 2010;40(7):657-64

6.

Bastion M, Siti Aishah S, Aida Zairani M, et al. Retrospective review of the adjunctive

use of pre-operative ranibizumab “LUCENTISTM” in the surgical management of diabetic retinopathy in a Tertiary Referral Hospital in Malaysia. Medicine & health 2010;5(2):93-102

http://journalarticle.ukm.my/2086/1/08MS090_4144.pdf

7.

Goh PP, Omar MA, Yusoff AF. Diabetic eye screening in Malaysia: findings from the National Health and Morbidity Survey 2006. Singapore Med J 2010;51(8):631-4

http://smj.sma.org.sg/5108/5108a2.pdf.

8. Goh PP, National Eye Database Study Group. Status of diabetic retinopathy among diabetics registered to the Diabetic Eye Registry, National Eye Database, 2007. Med J Malaysia 2008;63 Suppl C:24-8

9.

Hassan SS, Bong DB, Premsenthil M. Detection of neovascularization in diabetic retinopathy. J Digit Imaging 2012;25(3):437-44

10.

Helen CCT, Tajunisah I, Reddy SC. Adverse outcomes in type I diabetic pregnant women with proliferative diabetic retinopathy. Int J Ophthalmol 2011;4(4):443-6

11.

Keah RSH, Ch'ng KS. Prevalence of diabetic retinopathy in a primary care setting using digital retinal imaging technology. Malaysian Family Physician 2006;1(1):19-22

http://www.e-mfp.org/old/v1n1/pdf/diabetic_retinopathy.pdf

12.

Lim CP, Loo AV, Khaw KW, et al. Plasma, aqueous and vitreous homocysteine levels in proliferative diabetic retinopathy. Br J Ophthalmol 2012;96(5):704-7

Mallika P, Aziz S, Goh PP, et al. Diabetic retinopathy in native and non-native

Sarawakians--findings from the Diabetic Eye Registry. Med J Malaysia 2012;67(4):369-74

http://www.e-mjm.org/2012/v67n4/Diabetic-retinopathy.pdf

13.

Mallika PS, Lee PY, Cheah WL, et al. Risk factors for diabetic retinopathy in diabetics screened using fundus photography at a primary health care setting in east Malaysia. Malaysian Family Physician 2011;6(2&3):60-5

http://www.e-mfp.org/2011v6n2_3/pdf/risk_of_diabetic_retinopathy.pdf

14.

Mohammadreza P, Tajunisah I, Loo A, et al. Scanning laser edema index: a reliable tool to correlate with diabetic retinopathy and systemic risk factors? J Diabetes Complications 2012;26(3):210-3

http://umexpert.um.edu.my/file/publication/00008416_76660.pdf

15.

Ng ZX, Chua KH, Tajunisah I, et al. Soluble Receptor for Advanced Glycation End-Product (sRAGE)/Pentosidine Ratio: a potential risk factor determinant for type 2 diabetic retinopathy. Int J Mol Sci 2013;14(4):7480-91

16.

Ng ZX, Chua KH, Tajunisah I, et al. Attenuated levels of pro-inflammatory markers in diabetic retinopathy patients undergoing treatment with antihyperglycemic and antihypertensive drugs. Clinics (Sao Paulo) 2013;68(2):185-93

(3)

oxidative-glycation markers and sRAGE in diabetic retinopathy. Gene 2013;521(2):227-33

18. Ng ZX, Umah Rani K, Tajunisah I, et al. Investigation of SLC2A1 26177A/G gene polymorphism via high resolution melting curve analysis in Malaysian patients with diabetic retinopathy. J Diabetes Complications 2012;26(5):388-92

19.

Ng ZX, Umah Rani K, Poh R, et al. Lack of association between Gly82Ser, 1704G/T and 2184A/G of RAGE gene polymorphisms and retinopathy susceptibility in Malaysian diabetic patients. Genet Mol Res 2012;11(1):455-61

http://eprints.um.edu.my/3834/1/Lack_of_association_between_Gly82Ser,_1704GT_an d_2184AG_of_RAGE_gene_polymorphisms_and_the_retinopathy_susceptibility_in_Mala ysian_diabetic_patients..pdf.

20. Ng ZX, Umah Rani K, Tajunisah I, et al. Association analysis of -429T/C and -374T/A polymorphisms of receptor of advanced glycation end products (RAGE) gene in Malaysian with type 2 diabetic retinopathy. Diabetes Res Clin Pract 2012;95(3):372-7

21.

Ng ZX, Umah Rani K, Tajunisah I, et al. 2245G/A polymorphism of the receptor for

advanced glycation end-products (RAGE) gene is associated with diabetic retinopathy in the Malaysian population. Br J Ophthalmol 2012;96(2):289-92

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261748/pdf/bjophthalmol-2011-300658.pdf

22. Nor Sharina Y, Zunaina E, Shatriah I, et al. Correlation of retinal nerve fibre layer thickness with HbA1c and oxidised LDL in non-proliferative diabetic retinopathy. Journal of Diabetes & Metabolism 2013;4(8):1000298

http://omicsonline.org/correlation-of-retinal-nerve-fibre-layer-thickness-with-hba1c-and-oxidised-ldl-2155-6156.1000298.pdf

23. Norlaili M, Bakiah S, Zunaina E. Intravitreal triamcinolone versus laser photocoagulation as a primary treatment for diabetic macular oedema--a comparative pilot study. BMC Ophthalmol 2011;11:36,2415-11-36

24.

Ong MJ, Mohammadreza P, Tan CC, et al. Risk factors for clinically significant macular edema in a multi-ethnics population with type 2 diabetes. Int J Ophthalmol

2012;5(4):499-504

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428549/pdf/ijo-05-04-499.pdf

25.

Reddy SC, Kihn YM, Nurjahan MI, et al. Retinopathy in type 2 diabetic patients with microalbuminuria. Nepal J Ophthalmol 2013;5(1):69-74

http://nepjol.info/index.php/NEPJOPH/article/view/7830/6389

26.

Reddy SC, Tajunisah I, Low KP, et al. Prevalence of eye diseases and visual

impairment in urban population - A study from University of Malaya Medical Centre. Malaysian Family Physician 2008;3(1):25-8

http://www.e-mfp.org/old/2008v3n1/pdf/prevalence_eye_diseases.pdf

27. Reza AW, Eswaran C. A decision support system for automatic screening of non-proliferative diabetic retinopathy. J Med Syst 2011;35(1):17-24

28. Reza AW, Eswaran C, Dimyati K. Diagnosis of diabetic retinopathy: automatic extraction of optic disc and exudates from retinal images using marker-controlled watershed transformation. J Med Syst 2011;35(6):1491-501.

29. Reza AW, Eswaran C, Hati S. Diabetic retinopathy: a quadtree based blood vessel detection algorithm using RGB components in fundus images. J Med Syst

2008;32(2):147-55

30.

Rokiah O, Knight VF, Zainora M. The causes of low vision and pattern of prescribing at UKM Low Vision Clinic. Jurnal Sains Kesihatan Malaysia 2008;6(2):55-64

http://www.fskb.ukm.my/jurnal/jilid%206(2)2008/Chap%206.pdf

(4)

32.

Suresh S, Zunaina E, Shatriah I, et al. Sensitivity and specificity of HRT and OCT to detect diabetic macular edema. Journal of Diabetes & Metabolism 2012;S3:009

http://omicsonline.org/2155-6156/2155-6156-S3-009.pdf

33.

Tajunisah I, Nabilah H, Reddy SC. Prevalence and risk factors for diabetic retinopathy--a study of 217 pretinopathy--atients from University of Mretinopathy--alretinopathy--ayretinopathy--a Medicretinopathy--al Centre. Med J Mretinopathy--alretinopathy--aysiretinopathy--a 2006;61(4):451-6

http://www.e-mjm.org/2006/v61n4/Risk_Factors_Diabetic_Retinopathy.pdf

34.

Tan AK, Mallika PS, Aziz S, et al. Comparison between the PanOptic ophthalmoscope and the conventional direct ophthalmoscope in the detection of sight threatening diabetic retinopathy: The Kuching diabetic eye study. Malaysian Family Physician 2010;5(2):83-90

http://www.e-mfp.org/old/2010v5n2/pdf/Diabetic_Retinopathy.pdf.

35.

Thevi T, Maslina B, Reddy SC. Prevalence of eye diseases and visual impairment among the rural population - a case study of Temerloh Hospital. Malaysian Family Physician 2012;7(1):6-10

http://www.e-mfp.org/ojs/index.php/MFP/article/view/14.

36. Wan Nazaimoon WM, Ismail IS, G. R. Letchuman R, et al. Circulating levels of advanced glycosylation end-products and lipid peroxides in type 1 and type 2 diabetes mellitus patients with albuminuria and retinopathy. Journal of the ASEAN Federation of Endocrine Societies 2000;18(1):43-8

37.

Yang YF, Chong HH, Yang YK. Diabetic retinopathy in the community. Med J Malaysia 2001;56(1):104-5

http://www.e-mjm.org/2001/v56n1/Diabetic_Retinopathy.pdf

Case reports

1.

Ahmad SS, Shuaibah AG. Florid diabetic retinopathy in a young patient. J Ophthalmic Vis Res 2012;7(1):84-7

2. Bastion ML. Pneumatic retinopexy for treatment of posterior pole detachment following vitreoretinal surgery for diabetic tractional retinal detachment threatening the fovea. BMJ Case Rep 2012;2012:10.1136/bcr,2012-006303

3. Bastion ML, Mustapha M, Ho I. Brilliant crystallisation in the anterior chamber and subretinal space following adjunctive intravitreal ranibizumab for diabetic vitrectomy. BMJ Case Rep 2012;2012:10.1136/bcr,2012-007260

4.

Bastion ML, Barkeh HJ, Muhaya M. Accelerated diabetic retinopathy in pregnancy--a real and present danger. Med J Malaysia 2005;60(4):502-4

http://www.e-mjm.org/2005/v60n4/Diabetic_Retinopathy.pdf

5.

Malisa A, Mae-Lynn C. Dramatic response of iris and retinal neovascularisation

following usage of intravitreal ranibizumab as pre-operative adjunct in vitrectomy for advanced proliferative diabetic retinopathy. Journal of Surgical Academia

2011;1(1):67